Avidity Biosciences, Inc. (RNA)

Avidity Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	350.16	219.87	185.08	340.4	320.45	321.46
Short-Term Investments	1,526	1,282	410.27	270.33	85.1	6.68
Cash & Short-Term Investments	1,876	1,501	595.35	610.73	405.54	328.14
Cash Growth	18.08%	152.20%	-2.52%	50.59%	23.59%	246.95%
Accounts Receivable	-	-	1.11	2.36	0.9	1.2
Other Receivables	15.04	28.22	7.52	1.51	-	-
Receivables	15.04	28.22	8.62	3.88	0.9	1.2
Prepaid Expenses	15.15	12.57	7.33	8.34	4.7	2.34
Total Current Assets	1,966	1,542	611.31	622.94	411.14	331.68
Property, Plant & Equipment	74.35	18.29	16.65	15.01	15.59	1.92
Other Long-Term Assets	93.84	3.32	0.6	0.85	0.85	0.3
Total Assets	2,134	1,564	628.56	638.8	427.58	333.9
Accounts Payable	9.63	8.46	8.81	4.64	2.81	7.75
Accrued Expenses	137.16	64.73	39.87	39.13	20.22	3.15
Current Portion of Leases	3.97	3.84	3.64	3.11	1.77	-
Current Unearned Revenue	19.12	20.99	28.37	5.04	4.86	3.69
Total Current Liabilities	169.88	98.02	80.68	51.91	29.66	14.59
Long-Term Leases	46	2.96	6.21	7.58	9.96	0.94
Long-Term Unearned Revenue	32.07	37.96	40.9	1.24	6.53	12.15
Total Liabilities	247.94	138.94	127.79	60.73	46.15	27.68
Common Stock	0.02	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	3,225	2,315	1,071	939.31	566.16	372.76
Retained Earnings	-1,341	-893.07	-570.76	-358.54	-184.55	-66.54
Comprehensive Income & Other	1.77	2.9	0.13	-2.7	-0.19	-0.01
Total Common Equity	1,886	1,425	500.76	578.08	381.43	306.22
Shareholders' Equity	1,886	1,425	500.76	578.08	381.43	306.22
Total Liabilities & Equity	2,134	1,564	628.56	638.8	427.58	333.9
Total Debt	49.97	6.8	9.85	10.69	11.73	0.94
Net Cash (Debt)	1,826	1,495	585.5	600.04	393.81	327.2
Net Cash Growth	15.49%	155.29%	-2.42%	52.37%	20.36%	265.01%
Net Cash Per Share	13.90	13.40	8.02	11.50	9.51	15.10
Filing Date Shares Outstanding	150.68	120.21	79.72	70.81	47.75	37.58
Total Common Shares Outstanding	146.77	119.89	79.28	69.77	47.75	37.57
Working Capital	1,796	1,444	530.63	571.03	381.48	317.09
Book Value Per Share	12.85	11.89	6.32	8.29	7.99	8.15
Tangible Book Value	1,886	1,425	500.76	578.08	381.43	306.22
Tangible Book Value Per Share	12.85	11.89	6.32	8.29	7.99	8.15
Machinery	28.28	16.42	13.31	9.13	6.29	3.03
Construction In Progress	0.31	3.96	-	-	-	-
Leasehold Improvements	3.36	0.29	0.29	0.25	0.25	0.42

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q